SCY-078 antifungal activity in a murine model of invasive aspergillosis including azole-resistant strains

被引：0
|
作者：
Barat, S. [1 ]
Borroto-Esoda, K. [1 ]
Angulo, D. [1 ]
Holden, K. [2 ]
Warn, P. [2 ]
机构：
[1] Scynexis Inc, Jersey City, NJ USA
[2] Evotec UK, Manchester, Lancs, England
来源：
MYCOSES | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P313
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [21] Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis
    Wring, Stephen A.
    Randolph, Ryan
    Park, SeongHee
    Abruzzo, George
    Chen, Qing
    Flattery, Amy
    Garrett, Graig
    Peel, Michael
    Outcalt, Russell
    Powell, Kendall
    Trucksis, Michelle
    Angulo, David
    Borroto-Esoda, Katyna
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (04)
  • [22] Clinical implications of azole-resistant vs. azole-susceptible invasive aspergillosis in hematological malignancy (CLARITY) - a multicenter study
    Seidel, D.
    Cornely, O. A.
    Arenz, D.
    Meis, J. F.
    Vehreschild, J. J.
    Salmanton-Garcia, J.
    Zarrouk, M.
    Falces-Romero, I.
    Racil, Z.
    Lagrou, K.
    Maertens, J.
    Sharpe, A. Resendiz
    Blennow, O.
    Lass-Floerl, C.
    Le Govic, Y.
    Ostojic, A.
    Desoubeaux, G.
    Alakel, N.
    Schalk, E.
    Bergeron, A.
    Steinmann, J.
    Buchheidt, D.
    Stanzani, M.
    Klimko, N.
    Melchers, W. J. G.
    Vehreschild, M. J. G.
    Verweij, P. E.
    MYCOSES, 2019, 62 : 27 - 28
  • [23] Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis
    Rudramurthy, Shivaprakash M.
    Seyedmousavi, Seyedmojtaba
    Dhaliwal, Manpreet
    Chakrabarti, Arunaloke
    Meis, Jacques F.
    Mouton, Johan W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (01)
  • [24] Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim
    Kirchhoff, Lisa
    Dittmer, Silke
    Furnica, Dan-Tiberiu
    Buer, Jan
    Steinmann, Eike
    Rath, Peter-Michael
    Steinmann, Joerg
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (06) : 1645 - 1654
  • [25] Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1→3)-β-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis
    Petraitis, Vidmantas
    Petraitiene, Ruta
    Katragkou, Aspasia
    Maung, Bo Bo Win
    Naing, Ethan
    Kavaliauskas, Povilas
    Barat, Stephen
    Borroto-Esoda, Katyna
    Azie, Nkechi
    Angulo, David
    Walsh, Thomas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (06)
  • [26] High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance
    Takeda, Keita
    Suzuki, Junko
    Watanabe, Akira
    Arai, Teppei
    Koiwa, Tomohiro
    Shinfuku, Kyota
    Narumoto, Osamu
    Kawashima, Masahiro
    Fukami, Takeshi
    Tamura, Atsuhisa
    Nagai, Hideaki
    Matsui, Hirotoshi
    Kamei, Katsuhiko
    MEDICAL MYCOLOGY, 2021, 59 (04) : 327 - 334
  • [27] Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis
    George, D
    Miniter, P
    Andriole, VT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 86 - 91
  • [28] A PROSPECTIVE, PHASE 2, COMPARATIVE STUDY OF ORAL SCY-078 VS. STANDARD-OF-CARE FOLLOWING INTRAVENOUS ECHINOCANDIN THERAPY IN THE TREATMENT OF INVASIVE CANDIDIASIS (INCLUDING CANDIDEMIA)
    Pappas, Peter
    Helou, Silvia
    Angulo, David
    TRANSPLANT INTERNATIONAL, 2017, 30 : 311 - 311
  • [29] Pharmacodynamics and Dose-Response Relationships of Liposomal Amphotericin B against Different Azole-Resistant Aspergillus fumigatus Isolates in a Murine Model of Disseminated Aspergillosis
    Seyedmousavi, Seyedmojtaba
    Melchers, Willem J. G.
    Mouton, Johan W.
    Verweij, Paul E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1866 - 1871
  • [30] Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds
    Wakabayashi, H
    Abe, S
    Teraguchi, S
    Hayasawa, H
    Yamaguchi, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) : 1587 - 1591
12345